NCT00003238View on ClinicalTrials.gov

Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 1998

Primary Completion Date

October 31, 2001

Conditions
Prostate Cancer
Interventions
DRUG

perillyl alcohol

Trial Locations (8)

53545

Mercy Health System, Janesville

53715

Meriter Hospital, Madison

53792

University of Wisconsin Comprehensive Cancer Center, Madison

54401

North Central Oncology Associates, S.C., Wausau

54601

Gundersen Lutheran Medical Center, La Crosse

61032

Leonard C. Ferguson Cancer Center, Freeport

54307-3453

Green Bay Oncology, Ltd., Green Bay

53201-0342

Sinai Samaritan Medical Center - Milwaukee, Milwaukee

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT00003238 - Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | Biotech Hunter | Biotech Hunter